The World Health Summit brings together leading researchers, physicians, government officials and representatives from industry, non-governmental organizations (NGOs) and health care systems worldwide.
Among the confirmed speakers are:
(in alphabetical order)
Prior to becoming the Minister of Public Health, she was the Managing Director of Hamad Medical Corporation from 2007-2016. Under her leadership, HMC was transformed into an integrated academic health system and has achieved numerous international accreditations and awards. She sits on numerous boards of health related organizations, such as the JCI Middle East Advisory Council, the Association of Academic Health Centers International and the Institute of Global Health Innovation.
He is a veteran of the company, having joined in 1996 as a pharmaceutical consultant immediately after graduating from university with a biology degree. He then worked his way up the ranks in Germany including Head of Primary Care and Head of the company's Sales organization.
After studying economics he joined Bayer in the Corporate Finance Department. He held several international positions in the company, including member of the Executive Committee and Head of Central Administration & Organization at Bayer HealthCare and Chief Financial Officer of Bayer AG.
After a successful career, she retired from politics in 2003. Since 2006, she has headed Swissmedic, the Swiss supervisory authority for therapeutic products. In 2008, she was appointed permanent Vice-President of the ICRC. Her areas of focus include helping to ensure the cohesion, smooth running and development of governance mechanisms and internal control, as well as strengthening and developing relationships within the International Red Cross and Red Crescent Movement.
A physician specialized in tropical medicine and public health, he was one of the founding board members of the Global Fund in 2002 and has served in his current position since 2003. Prior to joining the Global Fund, he worked as a clinician and public health official in the UK, Germany and as Doctor-in-Charge of a rural hospital in Tanzania. He has more than 25 years of experience in global health and health advocacy with a special focus on AIDS and infectious diseases.
Formally the Senior Vice President and CFO for Philips Home Healthcare Solutions, he joined Philips from Baxter Healthcare, where he acted as the European Regional Controller. He accumulated more than 20 years of experience in the healthcare industry, recently completing about 25 M&A transactions with a particular focus on targets in the areas of Home Healthcare, Clinical Decision Support, Imaging and Image Guided Intervention and Treatment.
Elizabeth Blackburn won the 2009 Nobel Prize in Physiology or Medicine for discovering the molecular nature of telomeres and the co-discovery of telomerase. Both telomeres and telomerase are thought to play central roles in aging and diseases such as cancer. She has shown an abiding commitment to public service in the scientific, academic and public policy arenas, and helped to guide public science policy.
He was previously the Parliamentary Under Secretary of State at the Department of Health, where he was responsible for social services and mental health. Within this role he published guidelines to end the denial of adoptions purely on the basis of race.
Her previous roles at FIND included Chief Medical Officer (CMO) and Head of the TB program, where she was responsible for clinical evaluation of new tools for diagnosis of TB, malaria and neglected diseases. She has an extensive background in clinical evaluation and played a key role in FIND’s Xpert MTB/RIF feasibility. Prior to joining FIND in 2005, she worked as program coordinator for the Department of Infectious and Tropical Diseases in Munich, Germany, and established a TB research unit at Mbeya Medical Research Program in Tanzania.
An accomplished Corneal Surgeon and Ophthalmologist, Hélène Boisjoly is the first woman to hold the position of Dean of Faculty of Medicine at the University of Montreal and within the greater province of Quebec. She is the International President of the World Health Summit 2017.
A Professor of Global Public Health at the University of Strathclyde, he holds Honorary or Visiting Professorships at Glasgow University and Yale University as well. His research interests lie in disease prevention and translational research. He is founder and President of the World Prevention Alliance, a non-governmental organization committed to prevention research and actions in lower income countries.
He has a PhD in Health Administration, a Master in Public Health and Health Service Administration and graduated in Medicine. A specialist for Public Health, he is Professor at the National School of Public Health, at Universidade Nova de Lisboa, and taught and coordinated several university institutions in management and health administration. He was Senior Manager in health institutions such as Hospital de Santa Maria, Hospital Pulido Valente, Centro Hospitalar Lisboa Norte, Hospital de Cascais, SAMS Prestação Integrada de Cuidados de Saúde.
Previously a Senior Health Policy Analyst in the Health Division, she is now responsible for OECD work on health which aims at providing internationally comparable data on health systems and applying economic analysis to health policies, in this way advising policy makers, stakeholders and citizens on how to respond to healthcare demands.
Prior to joining IFPMA, he was Secretary General of Interpharma, the association of pharmaceutical research companies in Switzerland. For many years, he has been involved in the work of the European Federation of Pharmaceutical Industries and Associations, EFPIA, where he most recently served as Vice-Chair of the European Markets Committee and association representative on the Board. Prior to his appointment with Interpharma, he had a career as a journalist.
Working for the NCD Alliance since its founding in 2009, she holds experience in organizational and strategic development, global advocacy and policy-making, program design as well as capacity-building in low- and middle-income countries. Before joining the NCD Alliance, she worked at the International Diabetes Federation (IDF) in Brussels, leading their global advocacy program and establishing the first Women and Diabetes program.
A biochemist and structural biologist trained in basic sciences, his research activities have focused on different topics such as molecular virology, biochemistry, molecular biology, nuclear magnetic resonance, microbiology, structural biology, and bioinformatics. He has chaired numerous grant committees and has sat at councils including the Fondation pour la Recherche Médicale, European Molecular Biology Laboratory and Ecole Normale Supérieure Biology Dpt.
Responsible for running the global Healthcare Center of Excellence and accelerating growth through strategic partnerships, co-innovation efforts, and aligning SAP solutions with market needs, he has focused his career on driving value at the intersection of clinical, business and technology. Before joining SAP, he was Chief Medical Officer at MedAptus, a privately held, leading provider of revenue cycle management solutions to academic medical centers.
Manfred Dietel has headed the Institute for Anatomic Pathology at the Christian Albrecht University in Kiel since 1989. In 1993, he became Director of the Institute for Anatomic Pathology at the Charité, Humboldt-University in Berlin, and was Dean of its medical faculty from 1997-1999. From 2001-2004 he spent a stint as the Charité’s Medical Director and Managing Director.
He took office in July 2013 as incumbent Mayor of Addis Ababa, capital and largest city of Ethiopia. Prior to this, he served as Minister of Transport.
She held the Swiss Federal Department of Home Affairs, was the first woman ever to be elected President of the Confederation and won several referendums, including a revision of the Health Insurance Bill, the 10th revision of the social security system, and a drug policy based on prevention, therapy, help and rehabilitation. She is a member of the Council of Women World Leaders.
He worked in economic development and governance for several decades and founded Transparency International in 1993. Until 2011, he was the founding Chairman of the Extractive Industries Transparency Initiative. He is Honorary Professor at the Freie Universität Berlin. His academic career included teaching positions at the University of Frankfurt am Main, Harvard Kennedy School, Johns Hopkins School of Advanced International Studies and Georgetown University.
Professor Karl Max Einhäupl is a trained Neurologist. In 2004, he was awarded the German Federal Cross of Merit. From 1993-2008 Director of the Clinic for Neurology, Charité - Universitätsmedizin Berlin and from 2007 to 2008 Head of the Centre “CC15: Neurology, Neurosurgery and Psychiatry”. Since 2008, he is Chief Executive Officer of the Charité - Universitätsmedizin Berlin.
A professor of Public Health at University Descartes, Sorbonne Paris Cité, he is chair of the Centre Virchow Villermé de Santé Publique Paris-Berlin, co-chairs the European Academic Global Health Alliance, is president of the European Agency for Public Health Education Accreditation and Founding Director of the Institute of Global Health, University of Geneva. In 2016, Antoine Flahault was the International President of the World Health Summit.
With an impressive track record as a business executive - most recently as CEO of Lufthansa - and an exceptional global network, he has been a member of the Roche board since 2011 and was elected as Chair in 2014. He is a member of the Assembly of the International Committee of the Red Cross and Honorary Professor for Business Administration at University of St. Gallen.
A specialist in pharmacology and molecular medicine, Detlev Ganten is one of the world’s top scientists in the field of hypertension. He is the Founding President of the World Health Summit, a former CEO of the Charité – Universitätsmedizin Berlin and Founding Director and CEO of the Max Delbrück Center for Molecular Medicine.